Publicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (75)

2024

  1. Acyl-CoA binding protein for the experimental treatment of anorexia

    Science translational medicine, Vol. 16, Núm. 760, pp. eadl0715

2023

  1. High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP

    Aging Cell, Vol. 22, Núm. 1

2022

  1. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor

    Cell Death and Disease, Vol. 13, Núm. 4

  2. Correction: An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor (Cell Death & Disease, (2022), 13, 4, (356), 10.1038/s41419-022-04834-5)

    Cell Death and Disease

  3. Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models

    Frontiers in Medicine, Vol. 9

  4. Immunization of mice with the self-peptide ACBP coupled to keyhole limpet hemocyanin

    STAR Protocols, Vol. 3, Núm. 1

2021

  1. Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

    Cell Death and Disease, Vol. 12, Núm. 6

  2. Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype

    Cell Death and Disease, Vol. 12, Núm. 11

  3. In Vivo Imaging of Orthotopic Lung Cancer Models in Mice

    Methods in Molecular Biology (Humana Press Inc.), pp. 199-212

  4. Quantification of eIF2α Phosphorylation Associated with Mitotic Catastrophe by Immunofluorescence Microscopy

    Methods in Molecular Biology (Humana Press Inc.), pp. 217-226

2020

  1. Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade

    Journal of Investigative Dermatology, Vol. 140, Núm. 1, pp. 223-234.e7

  2. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

  3. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

    Nature Communications, Vol. 11, Núm. 1

  4. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)

    Nature Communications

2019

  1. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer (Nature Communications, (2019), 10, 1, (1486), 10.1038/s41467-019-09415-3)

    Nature Communications

  2. Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Nature Communications, Vol. 10, Núm. 1

  3. Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity

    OncoImmunology, Vol. 8, Núm. 11

  4. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion

    OncoImmunology, Vol. 8, Núm. 11

2018

  1. Calcium signaling and cell cycle: Progression or death

    Cell Calcium, Vol. 70, pp. 3-15

  2. Immune effectors responsible for the elimination of hyperploid cancer cells

    OncoImmunology, Vol. 7, Núm. 8